120 related articles for article (PubMed ID: 38143354)
1. Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice.
Lapeyre L; Piret J; Rhéaume C; Pons V; Uyar O; Préfontaine P; Rivest S; Boivin G
J Alzheimers Dis; 2024; 97(1):171-178. PubMed ID: 38143354
[TBL] [Abstract][Full Text] [Related]
2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease-associated β-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain.
Bocharova O; Pandit NP; Molesworth K; Fisher A; Mychko O; Makarava N; Baskakov IV
J Biol Chem; 2021 Jul; 297(1):100845. PubMed ID: 34052228
[TBL] [Abstract][Full Text] [Related]
4. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
6. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
7. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
Garad M; Edelmann E; Leßmann V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
[TBL] [Abstract][Full Text] [Related]
8. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
9. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
11. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
[TBL] [Abstract][Full Text] [Related]
12. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease.
Horibe S; Emoto T; Mizoguchi T; Tanaka T; Kawauchi S; Sasaki N; Yamashita T; Ikeda K; Emoto N; Hirata KI; Rikitake Y
Glia; 2024 Jan; 72(1):51-68. PubMed ID: 37610154
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
[TBL] [Abstract][Full Text] [Related]
14. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
15. Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice.
Collins JM; King AE; Woodhouse A; Kirkcaldie MTK; Vickers JC
J Neurotrauma; 2019 Jun; 36(11):1876-1889. PubMed ID: 30623730
[TBL] [Abstract][Full Text] [Related]
16. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
17. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.
He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM
Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120
[TBL] [Abstract][Full Text] [Related]
18. Aβ plaques do not protect against HSV-1 infection in a mouse model of familial Alzheimer's disease, and HSV-1 does not induce Aβ pathology in a model of late onset Alzheimer's disease.
Bocharova OV; Fisher A; Pandit NP; Molesworth K; Mychko O; Scott AJ; Makarava N; Ritzel R; Baskakov IV
Brain Pathol; 2023 Jan; 33(1):e13116. PubMed ID: 36064300
[TBL] [Abstract][Full Text] [Related]
19. (S)-[
Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
[TBL] [Abstract][Full Text] [Related]
20. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]